CN101757432A - Chinese medicine preparation for treating aplastic anemia - Google Patents
Chinese medicine preparation for treating aplastic anemia Download PDFInfo
- Publication number
- CN101757432A CN101757432A CN200910250275A CN200910250275A CN101757432A CN 101757432 A CN101757432 A CN 101757432A CN 200910250275 A CN200910250275 A CN 200910250275A CN 200910250275 A CN200910250275 A CN 200910250275A CN 101757432 A CN101757432 A CN 101757432A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- preparation
- aplastic anemia
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a Chinese medicine preparation for treating aplastic anemia. The preparation is prepared from the following raw materials in parts by weight: 10 parts of sanguisorba, 10 parts of fleece-flower root, 10 parts of antler gum, 10 parts of radix pseudostellariae, 12 parts of ophiopogon root, 12 parts of asparagus, 12 parts of yam, 12 parts of cortex moutan, 12 parts of radix paeoniae alba, 12 parts of cortex eucommiae, 15 parts of glossy privet fruit, 15 parts of yerbadetajo herba ecliptae, 15 parts of cimicifuga foetida, 15 parts of orange peel, 15 parts of cyrtomium rhizome, and 15 parts of dyers woad leaf. The preparation comprises all clinically accepted preparation types suitable for oral administration, preferably pills, powders, tablets, oral liquids and capsules prepared by the traditional preparation process or the modern preparation process. The selected drugs have the efficiency on preserving yin to nourish blood, nourishing the kidney and the liver, removing pathogenic heat from blood and promoting blood circulation for removing blood stasis by functioning together. The preparation has good effect on aplastic anemia caused by various reasons. Proved by clinic application, the invention has the advantages of obvious curative effect, no toxic or side effect, good tolerance property, and no recurrence after recovery.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation that is used for the treatment of aplastic anemia.
Background technology
Aplastic anemia is that marrow hemopoietic stem cells and the hematopoieticmicroenviron-ment damage that different pathogeny causes causes marrow failure, causes complete blood cell to generate and reduces by one group of syndrome.Chinese medicine claims that primary disease is " asthenia " disease.Clinical manifestation is an anemia, infection, hemorrhage.The medicine that is used for the treatment of aplastic anemia has Western medicine and Chinese medicine preparation.For example: Chinese patent medicine " Renshen Guipi Wan ", " Bazhen Pills ", " Bolus as a Kidney-Yin-Tonic ", " QIJU DIHUANG WAN " etc.Patent publication No. is the Chinese medicine for oral administration of CN101200497, with in the Radix Astragali, Radix Codonopsis, the Arillus Longan, the Radix Paeoniae Alba, Cortex Moutan, Herba Ecliptae, Carapax Trionycis, Herba Agrimoniae, the Radix Polygoni Multiflori etc. make oral preparations, are used for the treatment of aplastic anemia, its clinical effectiveness remains further to be improved.
Summary of the invention
The object of the present invention is to provide a kind of yin fluid astringing of nourishing blood that has, the Chinese medicine preparation of the effect of nourishing kidney tonifying liver, clearing away heat and cooling blood, promoting blood circulation to remove blood stasis, the aplastic anemia that causes at a variety of causes all has good effect.
The present invention has adopted following technical scheme:
Crude drug and the composition by weight thereof chosen are respectively: respectively 10 parts of Radix Sanguisorbae, Radix Polygoni Multiflori, Colla cornus cervi, Radix Pseudostellariaes; Respectively 12 parts of Radix Ophiopogonis, Radix Asparagi, Rhizoma Dioscoreae, Cortex Moutan, the Radix Paeoniae Alba, the Cortexs Eucommiae; Respectively 15 parts of Fructus Ligustri Lucidi, Herba Ecliptae, Rhizoma Cimicifugae, Pericarpium Citri Reticulatae, Rhizoma Osmundae, Folium Isatidiss; Its preparation comprises that acceptable is fit to all dosage forms of using for oral administration, pill, powder, tablet, oral liquid formulations, capsule preparations that first-selected utilization conventional formulation technology or modern preparation process are made clinically.
The crude drug that the present invention chooses is pure Chinese crude drug, Radix Sanguisorbae: cooling blood for hemostasis, skin ulcer is held back in detoxifcation.Radix Polygoni Multiflori: enrich and benefit essence and blood, detoxifcation, preventing the attack (or recurrence) of malaria, loosening bowel to relieve constipation.Radix Pseudostellariae: tonifying QI to produce body fluid.Radix Ophiopogonis: nourishing lung-YIN, reinforcing stomach reg fluid, the relieving restlessness that clears away heart-fire, loosening bowel to relieve constipation.Radix Asparagi: the lung heat clearing pathogenic fire reducing, nourshing Yin and drynsessmoistening prescription, loosening bowel to relieve constipation.Rhizoma Dioscoreae: supplementing QI and nourishing YIN, spleen reinforcing lung kidney, treating spontaneous emission and leukorrhagia.Cortex Moutan: clearing away heat and cooling blood, promoting blood circulation to remove blood stasis.The Radix Paeoniae Alba: the yin fluid astringing that nourishes blood, easing the affected liver to relieve pain is stabilized pain relieving, stabilizes pain relieving, suppressing liver-YANG.The Cortex Eucommiae: invigorating the liver and kidney, bone and muscle strengthening, antiabortive.Fructus Ligustri Lucidi: the nourishing kidney tonifying liver, reducing the asthenic fever makes eye bright.Rhizoma Cimicifugae: evacuate and bring down a fever rash, heat-clearing and toxic substances removing, elevate a turnable ladder yang-energy.Rhizoma Osmundae: parasite killing, heat-clearing and toxic substances removing, hemostasis.Folium Isatidis: heat-clearing and toxic substances removing, blood cooling and ecchymoses removing, relieving sore throat and diminishing swelling.
Selected medical material gathers the yin fluid astringing that nourishes blood altogether, the effect of nourishing kidney tonifying liver, clearing away heat and cooling blood, promoting blood circulation to remove blood stasis.The aplastic anemia that causes at a variety of causes all has good effect.Find that through clinical practice the present invention has the good effect that does not have recurrence after determined curative effect, without any side effects, better tolerance, the healing.
The specific embodiment
The Chinese medicine preparation that is used for the treatment of aplastic anemia of the present invention, crude drug and the composition by weight thereof chosen are respectively: respectively 10 parts of Radix Sanguisorbae, Radix Polygoni Multiflori, Colla cornus cervi, Radix Pseudostellariaes; Respectively 12 parts of Radix Ophiopogonis, Radix Asparagi, Rhizoma Dioscoreae, Cortex Moutan, the Radix Paeoniae Alba, the Cortexs Eucommiae; Respectively 15 parts of Fructus Ligustri Lucidi, Herba Ecliptae, Rhizoma Cimicifugae, Pericarpium Citri Reticulatae, Rhizoma Osmundae, Folium Isatidiss; Its preparation comprises that acceptable is fit to all dosage forms of using for oral administration, pill, powder, tablet, oral liquid formulations, capsule preparations that first-selected utilization conventional formulation technology or modern preparation process are made clinically.
Claims (1)
1. Chinese medicine preparation that is used for the treatment of aplastic anemia, it is characterized in that: crude drug and the composition by weight thereof chosen are respectively: each 10 parts of Radix Sanguisorbaes, Radix Polygoni Multiflori, Colla cornus cervi, Radix Pseudostellariae; Respectively 12 parts of Radix Ophiopogonis, Radix Asparagi, Rhizoma Dioscoreae, Cortex Moutan, the Radix Paeoniae Alba, the Cortexs Eucommiae; Respectively 15 parts of Fructus Ligustri Lucidi, Herba Ecliptae, Rhizoma Cimicifugae, Pericarpium Citri Reticulatae, Rhizoma Osmundae, Folium Isatidiss; Its preparation comprises that acceptable is fit to all dosage forms of using for oral administration, pill, powder, tablet, oral liquid formulations, capsule preparations that first-selected utilization conventional formulation technology or modern preparation process are made clinically.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910250275A CN101757432A (en) | 2009-12-11 | 2009-12-11 | Chinese medicine preparation for treating aplastic anemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910250275A CN101757432A (en) | 2009-12-11 | 2009-12-11 | Chinese medicine preparation for treating aplastic anemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101757432A true CN101757432A (en) | 2010-06-30 |
Family
ID=42488916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910250275A Pending CN101757432A (en) | 2009-12-11 | 2009-12-11 | Chinese medicine preparation for treating aplastic anemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101757432A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104258083A (en) * | 2014-10-21 | 2015-01-07 | 王婷 | Traditional Chinese medicine composition for treating chronic aplastic anemia |
-
2009
- 2009-12-11 CN CN200910250275A patent/CN101757432A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104258083A (en) * | 2014-10-21 | 2015-01-07 | 王婷 | Traditional Chinese medicine composition for treating chronic aplastic anemia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101972454B (en) | Medicament for treating lymphoma | |
| CN102225138B (en) | Traditional Chinese medicine composition for treating fracture and preparation method and application thereof | |
| CN102370949A (en) | Chinese medicinal compound preparation for treating cholecystitis and preparation method thereof | |
| CN1103223C (en) | Chinese medicine for treating cholecystitis | |
| CN1931329A (en) | Stomatocase treating medicine | |
| CN101703742B (en) | Preparation method of granules for treating acne caused by qi deficiency causing blood stasis and phlegm-heat stagnation | |
| CN101670089A (en) | Traditional Chinese medicine for treating acute gastroenteritis | |
| CN101757312A (en) | Chinese medicine preparation for treating thrombocytopenia | |
| CN103656122B (en) | Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof | |
| CN108543044B (en) | Combined medicine for treating acne and application thereof | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
| CN105311492A (en) | Medicine for treating coronary atherosclerotic heart disease | |
| CN105362904A (en) | Qi tonifying and blood nourishing traditional Chinese medicinal pill and preparation method thereof | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| CN101954022B (en) | Chinese medicinal composition for treating lung cancer | |
| CN1086144C (en) | Capsule for tonifying kidney | |
| CN101757432A (en) | Chinese medicine preparation for treating aplastic anemia | |
| CN1178682C (en) | Angiocardiopathy treating traditional Chinese medicine | |
| CN104042839A (en) | Traditional Chinese medicine composition for treating tinea versicolor | |
| CN107551182A (en) | A kind of Chinese traditional compound medicine for being used to treat hepatic disorder | |
| CN112691168B (en) | Traditional Chinese medicine composition for preventing and treating nuclear radiation injury and preparation method thereof | |
| CN103070969A (en) | Chinese medicinal composition for reducing blood fat and preparation method thereof | |
| CN102284023A (en) | Chinese medicinal composition for treating asthma | |
| CN101966329A (en) | Medicament for treating rash | |
| CN101991762A (en) | Traditional Chinese medicine for treating refractory asthma and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20100630 |